Regional Health (RHEP) CEO adds common and preferred shares

Filing Impact

(Neutral)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

REGIONAL HEALTH PROPERTIES, INC CEO and President Brent Morrison reported multiple insider purchases. Through an IRA, he bought 5,000 shares of common stock on June 5, 2026 at $1.15 per share and 10,000 common shares on May 29, 2026 at $1.18 per share in open-market transactions.

He also purchased 5,000 shares of Series D 8% Cumulative Convertible Redeemable Preferred Shares on May 27, 2026 at $2.02 per share through the same IRA. After these trades, the IRA holds 22,272 common shares and 17,000 preferred shares, while a separate direct holding shows 309,499 common shares as of May 27, 2026.

Insights

CEO is a net buyer, adding modest exposure via IRA.

CEO Brent Morrison executed open-market purchases totaling 15,000 common shares at prices of $1.15 and $1.18, plus 5,000 Series D preferred shares at $2.02. These are discretionary buys rather than option exercises or tax-related moves.

The filing also shows a sizable direct position of 309,499 common shares as of May 27, 2026, so the 20,000 newly purchased securities represent a relatively small percentage of his overall exposure. Overall, this looks like routine incremental insider buying rather than a thesis-changing transaction.

Insider Trade Summary

Net Buyer: 20,000 shares ($27,650)

Net Buy 4 txns

Insider Morrison Brent

Role CEO and President

Bought 20,000 shs ($28K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$1.15	$6K
Purchase	Common Stock	10,000	$1.18	$12K
Purchase	Series D 8% Cumulative Conv. Redeemable Preferred Shares	5,000	$2.02	$10K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 22,272 shares (Indirect, By IRA); Series D 8% Cumulative Conv. Redeemable Preferred Shares — 17,000 shares (Indirect, By IRA); Common Stock — 309,499 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Common stock buy (Jun 5, 2026): 5,000 shares at $1.15 Common stock buy (May 29, 2026): 10,000 shares at $1.18 Preferred stock buy (May 27, 2026): 5,000 shares at $2.02 +4 more

7 metrics

Common stock buy (Jun 5, 2026) 5,000 shares at $1.15 Indirect IRA open-market purchase of common stock

Common stock buy (May 29, 2026) 10,000 shares at $1.18 Indirect IRA open-market purchase of common stock

Preferred stock buy (May 27, 2026) 5,000 shares at $2.02 Indirect IRA purchase of Series D 8% preferred

IRA common holdings after trades 22,272 shares Common stock held indirectly following June 5, 2026 purchase

IRA preferred holdings after trades 17,000 shares Series D 8% preferred held indirectly after May 27, 2026

Direct common holdings 309,499 shares Common stock held directly as of May 27, 2026

Net shares bought 20,000 shares Net buy across reported transactions in this Form 4

Key Terms

open-market purchase, indirect ownership, IRA, Series D 8% Cumulative Conv. Redeemable Preferred Shares, +1 more

5 terms

open-market purchase financial

"transaction_action: open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type: indirect, nature_of_ownership: By IRA"

IRA financial

"nature_of_ownership: By IRA"

An individual retirement account (IRA) is a savings account designed to help people put aside money for their retirement, often with tax advantages that encourage long-term savings. It matters to investors because it can grow over time, providing financial security later in life, and offers benefits that can reduce current taxes or allow investments to compound more effectively.

Series D 8% Cumulative Conv. Redeemable Preferred Shares financial

"security_title: Series D 8% Cumulative Conv. Redeemable Preferred Shares"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/08/2026 - 04:34 PM Accepted by SEC EDGAR 06/08/2026 - 04:33 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Brent

(Last)

(First)

(Middle)

C/O REGIONAL HEALTH PROPERTIES, INC

1050 CROWN POINTE PARKWAY SUITE 720

(Street)

ATLANTA

GEORGIA

30338

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								309,499	D
Common Stock	05/29/2026		P		10,000	A	$1.18⁽¹⁾	17,272	I	By IRA
Common Stock	06/05/2026		P		5,000	A	$1.15	22,272	I	By IRA
Series D 8% Cumulative Conv. Redeemable Preferred Shares	05/27/2026		P		5,000	A	$2.02	17,000	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were affected

	/s/ Brent Morrison	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did RHEP CEO Brent Morrison buy in this Form 4 filing?

Brent Morrison bought 15,000 shares of REGIONAL HEALTH PROPERTIES common stock and 5,000 Series D preferred shares. All purchases were open-market trades executed through his IRA at prices between about $1.15 and $2.02 per share.

At what prices did Brent Morrison purchase RHEP common stock?

He bought 5,000 common shares at $1.15 per share on June 5, 2026, and 10,000 common shares at $1.18 per share on May 29, 2026. Both transactions were reported as open-market purchases through his IRA.

How many Regional Health (RHEP) preferred shares did the CEO purchase?

Morrison purchased 5,000 Series D 8% Cumulative Convertible Redeemable Preferred Shares at $2.02 per share on May 27, 2026. These preferred shares were acquired indirectly through his IRA and brought that IRA’s preferred holdings to 17,000 shares.

What are Brent Morrison’s indirect IRA holdings in RHEP after these trades?

After the reported trades, his IRA holds 22,272 REGIONAL HEALTH PROPERTIES common shares and 17,000 Series D preferred shares. These figures reflect cumulative positions following the June 5, May 29, and May 27, 2026 purchases disclosed in the Form 4.

How many RHEP common shares does the CEO hold directly after these transactions?

The filing shows a direct holding of 309,499 REGIONAL HEALTH PROPERTIES common shares as of May 27, 2026. This direct position is separate from his IRA holdings and provides important context for the scale of his recent incremental purchases.

Were Brent Morrison’s RHEP purchases part of an option exercise or a tax event?

No, the transactions are coded as open-market purchases (code P) of non-derivative securities. The filing does not show option exercises, tax-withholding dispositions, or derivative activity, indicating these are straightforward buy decisions rather than mechanical compensation events.